Understanding the differential roles of cytoplasmic and nuclear SIRT1 in tumor pathophysiology could also open avenues for targeted therapies to improve patient outcomes by modulating SIRT1 localization and activity. This evidence concerns the gene SIRT1 and neoplasm.